Keywords: sumitomo, licensing, novirio, hep, drug, pharmaceuticals, based

Sumitomo licensing Novirio's hep B drug

Article | 03 July 2001

Print This

Sumitomo Pharmaceuticals, based in Osaka, Japan, has signed a licensingagreement with Novirio of the USA, with reference to the latter's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in